Infectious Diseases Vaccibody Norway - Vaccibody.com
215
page-template-default,page,page-id-215,bridge-core-2.4.3,ajax_updown_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-,qode-theme-ver-22.8,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.3.0,vc_responsive

Infectious Diseases

Generation of rapid, strong and long-lasting antibody responses is crucial for development of effective vaccines against infectious diseases.

Vaccibody has over the last years generated promising pre-clinical data in different infectious disease models like Influenza, Ebola, Herpes Simplex Virus 2 and Tuberculosis.

 

The studies have shown that Vaccibody vaccines are able to protect against infectious diseases through generation of neutralizing antibodies and CD4+ T cell responses after a single administration with a needle-free jet injector.

 

Research is being conducted to leverage Vaccibody’s vaccine technology to develop vaccines to prevent or treat infectious diseases.